Clinical Trials in New York

Showing 13001-13020 of 22,668 trials

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

NCT03880123

The main purpose of this study is to establish a safe and tolerable dose combination (the "maximum tolerated dose") of selinexor and ixazomib when used together for the treatment of patients with certain types of advanced sarcoma. The study will enroll patients with advanced dedifferentiated liposarcoma, malignant peripheral nerve sheath tumor, alveolar soft part sarcoma and Ewing sarcoma. Future studies to further evaluate the safety and anti-cancer efficacy of this treatment for sarcoma will use the dose combination determined in this study.

LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part Sarcoma+2 more

Matthew InghamStarted Nov 2020

New York, New York, United States

COMPLETEDPhase 2< 1 mile

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

NCT00428714

The purpose is to see how quickly two different types of prostate cancer participants respond when taking enzastaurin. Cohort 1 - asymptomatic participants with androgen-independent prostate-specific antigen (PSA)-progressive disease without clinical or radiographic evidence of metastatic disease. Cohort 2 - participants with androgen-independent metastatic prostate cancer (documented bone or soft tissue metastases) with rising PSA, clinical, radiographic disease progression following one prior docetaxel-based regimen

Prostate Cancer

Eli Lilly and Company73 participantsStarted Jan 2007

Los Angeles, California, United States • Stanford, California, United States • New Haven, Connecticut, United States +8 more locations

Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy

Find Trials by Condition in New York

A Study to Test the Combination of Selinexor (KPT-330), Ixazomib, and Dexamethasone in Patients With Myeloma

Food Order Intervention for Gestational Diabetes

Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL

Neural Mechanisms of Disulfiram Effects

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A

Expanded Access for Marizomib

An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients

Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults

Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo

Efficacy, Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients at Early Stage of the Disease

A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL

Study of Ataluren for Previously Treated Participants With Nonsense Mutation Duchenne/Becker Muscular Dystrophy (nmDBMD) in Europe, Israel, Australia, and Canada